November 16, 2026, 12 PM EDT
Virtual
New cancer treatments can offer meaningful advances—but increasingly high drug prices raise difficult questions about affordability and access. NBCC joins Dr. Lee Newcomer and Dr. Daniel Goldstein for a discussion of why cancer drugs launch at the prices they do in the United States, how the current system might better reward meaningful innovation while ensuring access to effective treatments, and what U.S. pricing means for patients and health systems around the world. The conversation will also explore how breast cancer advocates can help push for a more rational, affordable, and accessible system of cancer care.
